Medical and Pharmaceutical Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment Relacorilant is designed to address disorders linked to the stress hormone cortisol Joseph MortonMarch 31, 2025
Health & Wellness EverythingALS and NeuroSense take aim at Lou Gehrig’s disease ALS affects up to 30,000 people in the United States with 5,000 new cases every year, according to John Hopkins Medicine. Joseph MortonAugust 2, 2022